You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-marketing

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Cataract Trial in Buenos Aires

Completed
  • Cataract
    • Buenos Aires, Argentina
      Dr. Nano Eye Clinic
    Oct 10, 2023

    Crohn Disease Trial in Beijing (Infliximab)

    Not yet recruiting
    • Crohn Disease
    • Beijing, China
      Beijing Children's Hospital, Capital Medical University
    Jun 13, 2023

    Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

    Recruiting
    • SARS-CoV-2
    • SPIKEVAX
    • New York, New York
      Aetion, Inc
    Nov 8, 2023

    Pelvic Osteotomy, Acetabular Dysplasia, Periacetabular Osteotomy Trial in Birmingham (MyPAO)

    Recruiting
    • Pelvic Osteotomy
    • +2 more
    • MyPAO
    • Birmingham, United Kingdom
      The Royal Orthopaedic Hospital NHS Trust
    Sep 7, 2023

    CTAG Dissection/Trauma Post Marketing Surveillance Japan

    Completed
    • Thoracic Aortic Aneurysm
    • +2 more
    • Conformable GORE® TAG® Thoracic Endoprosthesis
    • (no location specified)
    Jan 11, 2023

    Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia

    Not yet recruiting
    • Myelodysplastic Syndrome
    • Beta Thalassemia
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Assess Safety of Ozanimod in Moderate to Severe Active UC in

    Not yet recruiting
    • Ulcerative Colitis
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Oral azacitidine
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Study Assessing Safety and Efficacy of Nerivio for Migraine

    Recruiting
    • Migraine
    • Nerivio
    • Bridgewater, New Jersey
      Theranica Inc USA
    Jul 10, 2023

    Besponsa Post Marketing Surveillance Study

    Active, not recruiting
    • Hematologic Maligmancy
    • Inotuzumab ozogamicin
    • Seoul, Korea, Republic of
      Pfizer
    Oct 10, 2022

    Saphir Stem in Primary Hip Surgery

    Recruiting
    • Arthropathy of Hip
    • hip arthroplasty with prosthesis
    • Toulouse, France
      Hopital Ducuing
    Dec 12, 2022

    Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

    Not yet recruiting
    • Metastatic ALK+ Non Small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Pfizer
    Jan 24, 2023

    Juvenile Idiopathic Arthritis

    Not yet recruiting
    • Psoriatic Arthritis, Juvenile
    • Polyarticular Juvenile Idiopathic Arthritis
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 22, 2023

    Assess Deucravacitinib Post-marketing Surveillance in Psoriasis

    Not yet recruiting
    • Psoriasis
      • Tosima-ku, Tokyo, Japan
        Local Institution
      Nov 22, 2022

      Korean Regulatory Post Marketing Surveillance for Somavert

      Not yet recruiting
      • Acromegaly
      • (no location specified)
      Jul 18, 2022

      Heart Failure Trial in Osaka (Samtasu for I.V. infusion)

      Not yet recruiting
      • Heart Failure
      • Samtasu for I.V. infusion
      • Osaka, Japan
        Pharmacovigilance Department
      Jan 25, 2023

      Xeljanz (Registered) in Ulcerative Colitis Patients

      Completed
      • Ulcerative Colitis
      • Non-intervention
      • Seoul, Korea, Republic of
        Pfizer
      Nov 16, 2022

      Korean Post-marketing Surveillance for Xeljanz XR

      Recruiting
      • Active Moderate to Severe Rheumatoid Arthritis
      • Active Ankylosing Spondylitis
      • Tofacitinib XR
      • Seoul, Korea, Republic of
        Pfizer
      Oct 10, 2022

      Safety Issues Trial in Surabaya (Diphtheria Antitoxin)

      Completed
      • Safety Issues
      • Diphtheria Antitoxin
      • Surabaya, East Java, Indonesia
        RSUD Dr. Soetomo
      Sep 19, 2023

      Brivaracetam:Prospective and Multicentre Post-marketing

      Active, not recruiting
      • Epilepsy
      • Montréal, Quebec, Canada
        Centre Hospitalier de l'Université de Montréal (CHUM)
      Jan 18, 2023

      Korea Post Marketing Surveillance (PMS) Study of Vizimpro

      Enrolling by invitation
      • Lung Neoplasms
      • Seoul, Korea, Republic of
        Pfizer
      Sep 21, 2022

      BIOFLOW-china Post-marketing Study (BIOTRONIK)

      Not yet recruiting
      • In-Stent Stenosis (Restenosis) of Coronary Artery Stent
      • Native Coronary Artery Stenosis
      • BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
      • Harbin, Heilongjiang, China
        The Fourth Affiliated Hospital of Harbin Medical University
      Dec 26, 2022

      Korea Post Marketing Surveillance (PMS) Study of Talzenna®

      Not yet recruiting
      • Breast Neoplasms
      • (no location specified)
      Aug 1, 2022

      Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases

      Active, not recruiting
      • Lung Diseases, Interstitial
      • Tokyo, Japan
        Nippon Boehringer Ingelheim Co., Ltd.
      Jan 9, 2023